Brief: Y-Mabs Announces Partnership Regarding Early Access Program For Danyelza (Naxitamab-Gqgk) In Europe
21/12/2022 14:02
Y-mAbs Therapeutics Inc YMAB.O :
* Y-MABS ANNOUNCES PARTNERSHIP REGARDING EARLY ACCESS
PROGRAM FOR
DANYELZA (NAXITAMAB-GQGK) IN EUROPE
* Y-MABS THERAPEUTICS INC - ENTERED INTO A DISTRIBUTION
AGREEMENT
WITH WEP CLINICAL
Source text for Eikon: ID:nGNX8yF9xW
Further company coverage: YMAB.O
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary